Meta-analysis of microRNA-183 family expression in human cancer studies comparing cancer tissues with noncancerous tissues

Gene

Volumn 527, Issue 1, 2013, Pages 26-32

  Zhang, Qing He ^a   Sun, Hong Min ^a   Zheng, Rui Zhi ^a   Li, Ying Chun ^a   Zhang, Qian ^a   Cheng, Pan ^a   Tang, Zhen Hai ^a   Huang, Fen ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Cancer; Meta analysis; MicroRNA 183 family; Tissue

Indexed keywords

BIOLOGICAL MARKER; MICRORNA; MICRORNA 183; UNCLASSIFIED DRUG;

BLADDER CANCER; BREAST CANCER; CANCER GROWTH; CANCER PROGNOSIS; CANCER RESEARCH; CANCER TISSUE; CLINICAL FEATURE; COLON CANCER; COLORECTAL CANCER; DOWN REGULATION; EARLY CANCER; ENDOMETRIUM CANCER; GENE EXPRESSION; HUMAN; LIVER CELL CARCINOMA; LUNG CANCER; META ANALYSIS; NEOPLASM; OSTEOSARCOMA; OVARY CARCINOMA; PANCREAS CANCER; PRIORITY JOURNAL; PROSTATE CANCER; RECTUM CANCER; REVIEW; STOMACH CANCER; THYROID CARCINOMA; UPREGULATION; UTERINE CERVIX CANCER;

BASAL CELL CARCINOMA; BCC; BLADDER UROTHELIAL CARCINOMA; CANCER; CARCINOMA IN SITU CELLS OF THE TESTIS; CIS; FC; FOLD CHANGE; HCC; HEPATOCELLULAR CARCINOMA; HG-SOC; HIGH-GRADE SEROUS OVARIAN CARCINOMA; HMCS; HUMAN NORMAL PLEURAL MESOTHELIAL SHORT-TERM CELL CULTURES; LUNG SQUAMOUS CELL CARCINOMA; MALIGNANT PLEURAL MESOTHELIOMA; META-ANALYSIS; MICRORNA-183 FAMILY; MIR, MICRORNA; MIRNA; MPM; NON-SMALL CELL LUNG CANCER; NSCC; PANCREATIC DUCTAL ADENOCARCINOMA; PANCREATIC INTRAEPITHELIAL NEOPLASMS; PANINS; PDAC; QRT-PCR; QUANTITATIVE REAL-TIME REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCC; TISSUE; UC;

GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; NEOPLASMS;

EID: 84881224445     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2013.06.006     Document Type: Review

References (64)

1. Abraham D., et al. MicroRNA profiling of sporadic and hereditary medullary thyroid cancer identifies predictors of nodal metastasis, prognosis, and potential therapeutic targets. Clin. Cancer Res. 2011, 17(14):4772-4781.
2. Balatti V., et al. MicroRNAs dysregulation in human malignant pleural mesothelioma. J. Thorac. Oncol. 2011, 6(5):844-851.
3. Bandres E., et al. Identification by real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Mol. Cancer 2006, 5:29.
4. Bartels C.L., Tsongalis G.J. MicroRNAs: novel biomarkers for human cancer. Clin. Chem. 2009, 55(4):623-631.
5. Cekaite L., et al. MiR-9, -31, and -182 deregulation promote proliferation and tumor cell survival in colon cancer. Neoplasia 2012, 14(9):868-879.
6. Chan S.K., Griffith O.L., Tai I.T., Jones S.J. Meta-analysis of colorectal cancer gene expression profiling studies identifies consistently reported candidate biomarkers. Cancer Epidemiol. Biomarkers Prev. 2008, 17(3):543-552.
7. Cho W.C., Chow A.S., Au J.S. Restoration of tumour suppressor hsa-miR-145 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor receptor mutation. Eur. J. Cancer 2009, 45(12):2197-2206.
8. Dettmer M., et al. MicroRNA expression array identifies novel diagnostic markers for conventional and oncocytic follicular thyroid carcinomas. J. Clin. Endocrinol. Metab. 2013, 98(1):E1-E7.
9. Donnem T., et al. MicroRNA signatures in tumor tissue related to angiogenesis in non-small cell lung cancer. PLoS One 2012, 7(1):e29671.
10. Earle J.S. Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma. J. Mol. Diagn. 2010, 12(4):433-440.
11. Fan C., Chen C., Wu D. The association between common genetic variant of microRNA-499 and cancer susceptibility: a meta-analysis. Mol. Biol. Rep. 2012.
12. Giricz O., et al. Hsa-miR-375 is differentially expressed during breast lobular neoplasia and promotes loss of mammary acinar polarity. J. Pathol. 2012, 226(1):108-119.
13. Goeppert B., et al. Down-regulation of tumor suppressor A kinase anchor protein 12 in human hepatocarcinogenesis by epigenetic mechanisms. Hepatology 2010, 52(6):2023-2033.
14. Griffith O.L., Melck A., Jones S.J., Wiseman S.M. Meta-analysis and meta-review of thyroid cancer gene expression profiling studies identifies important diagnostic biomarkers. J. Clin. Oncol. 2006, 24(31):5043-5051.
15. Guan P., Yin Z., Li X., Wu W., Zhou B. Meta-analysis of human lung cancer microRNA expression profiling studies comparing cancer tissues with normal tissues. J. Exp. Clin. Cancer Res. 2012, 31:54.
16. Han Y., et al. MicroRNA expression signatures of bladder cancer revealed by deep sequencing. PLoS One 2011, 6(3):e18286.
17. Hannafon B.N., Sebastiani P., de Las M.A., Lu J., Rosenberg C.L. Expression of microRNA and their gene targets are dysregulated in preinvasive breast cancer. Breast Cancer Res. 2011, 13(2):R24.
18. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA Cancer J. Clin. 2011, 61(2):69-90.
19. Jiang L., et al. miR-182 as a prognostic marker for glioma progression and patient survival. Am. J. Pathol. 2010, 177(1):29-38.
20. Kong W.Q., et al. MicroRNA-182 targets cAMP-responsive element-binding protein 1 and suppresses cell growth in human gastric adenocarcinoma. FEBS J. 2012, 279(7):1252-1260.
21. Larne O., et al. miQ-a novel microRNA based diagnostic and prognostic tool for prostate cancer. Int. J. Cancer 2013, 132(12):2867-2875.
22. Lee H., Choi H.J., Kang C.S., Lee H.J., Lee W.S., Park C.S. Expression of miRNAs and PTEN in endometrial specimens ranging from histologically normal to hyperplasia and endometrial adenocarcinoma. Mod. Pathol. 2012, 25(11):1508-1515.
23. Lehmann U., et al. Identification of differentially expressed microRNAs in human male breast cancer. BMC Cancer 2010, 10:109.
24. Li J., et al. miR-183 inhibits TGF-beta1-induced apoptosis by downregulation of PDCD4 expression in human hepatocellular carcinoma cells. BMC Cancer 2010, 10:354.
25. Li X., et al. Identification of new aberrantly expressed miRNAs in intestinal-type gastric cancer and its clinical significance. Oncol. Rep. 2011, 26(6):1431-1439.
26. Li X., Zhang G., Li Q., Xu M., Feng D., Wu W. Identification of aberrantly expressed miRNAs in rectal cancer. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2012, 37(7):662-668.
27. Li X., et al. Identification of aberrantly expressed miRNAs in rectal cancer. Oncol. Rep. 2012, 28(1):77-84.
28. Lin H., et al. Unregulated miR-96 induces cell proliferation in human breast cancer by downregulating transcriptional factor FOXO3a. PLoS One 2010, 5(12):e15797.
29. Lin S., et al. Aberrant microRNAs expression in CD133(+)/CD326(+) human lung adenocarcinoma initiating cells from A549. Mol. Cells 2012, 33(3):277-283.
30. Liu Z., et al. MiR-182 overexpression in tumourigenesis of high-grade serous ovarian carcinoma. J. Pathol. 2012, 228(2):204-215.
31. Liu A.M., et al. Circulating miR-15b and miR-130b in serum as potential markers for detecting hepatocellular carcinoma: a retrospective cohort study. BMJ Open 2012, 2(2):e825.
32. Liu Y., et al. Synthetic miRNA-mowers targeting miR-183-96-182 cluster or miR-210 inhibit growth and migration and induce apoptosis in bladder cancer cells. PLoS One 2012, 7(12):e52280.
33. Lowery A.J., Miller N., Dwyer R.M., Kerin M. Dysregulated miR-183 inhibits migration in breast cancer cells. BMC Cancer 2010, 10:502.
34. Ma Q., Yang L., Wang C., Yu Y.Y., Zhou B., Zhou Z.G. Differential expression of colon cancer microRNA in microarray study. Sichuan Da Xue Xue Bao Yi Xue Ban 2011, 42(3):344-348.
35. Ma L., et al. An integrated analysis of miRNA and mRNA expressions in non-small cell lung cancers. PLoS One 2011, 6(10):e26502.
36. Ma Y., Zhang P., Yang J., Liu Z., Yang Z., Qin H. Candidate microRNA biomarkers in human colorectal cancer: systematic review profiling studies and experimental validation. Int. J. Cancer 2012, 130(9):2077-2087.
37. Mihelich B.L., et al. miR-183-96-182 cluster is overexpressed in prostate tissue and regulates zinc homeostasis in prostate cells[J]. J Biol Chem 2011, 286(52):44503-44511.
38. Motoyama K., et al. Over- and under-expressed microRNAs in human colorectal cancer. Int. J. Oncol. 2009, 34(4):1069-1075.
39. Myatt S.S., et al. Repression of FOXO1 expression by microRNAs in endometrial cancer. Cancer Res. 2010, 70(1):367-377.
40. Novotny G.W., et al. MicroRNA expression profiling of carcinoma in situ cells of the testis. Endocr. Relat. Cancer 2012, 19(3):365-379.
41. Pierce M.L., Weston M.D., Fritzsch B., Gabel H.W., Ruvkun G., Soukup G.A. MicroRNA-183 family conservation and ciliated neurosensory organ expression. Evol. Dev. 2008, 10(1):106-113.
42. Pignot G., et al. MicroRNA expression profile in a large series of bladder tumors: identification of a 3-miRNA signature associated with aggressiveness of muscle-invasive bladder cancer. Int. J. Cancer 2012.
43. Pineau P., et al. miR-221 overexpression contributes to liver tumorigenesis. Proc. Natl. Acad. Sci. U. S. A. 2010, 107(1):264-269.
44. Sand M., et al. Expression of microRNAs in basal cell carcinoma. Br. J. Dermatol. 2012, 167(4):847-855.
45. Sarver A.L., et al. Human colon cancer profiles show differential microRNA expression depending on mismatch repair status and are characteristic of undifferentiated proliferative states. BMC Cancer 2009, 9:401.
46. Schaefer A., et al. Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma. Int. J. Cancer 2010, 126(5):1166-1176.
47. Siva A.C., et al. Molecular assays for the detection of microRNAs in prostate cancer. Mol. Cancer 2009, 8:17.
48. Slaby O., et al. Expression of miRNA-106b in conventional renal cell carcinoma is a potential marker for prediction of early metastasis after nephrectomy. J. Exp. Clin. Cancer Res. 2010, 29:90.
49. Szafranska A.E., et al. MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma. Oncogene 2007, 26(30):4442-4452.
50. Tan X., et al. A 5-microRNA signature for lung squamous cell carcinoma diagnosis and hsa-miR-31 for prognosis. Clin. Cancer Res. 2011, 17(21):6802-6811.
51. Tang T., et al. MicroRNA-182 plays an onco-miRNA role in cervical cancer. Gynecol. Oncol. 2013, 129(1):199-208.
52. Tsuchiyama K., et al. Expression of microRNAs associated with Gleason grading system in prostate cancer: miR-182-5p is a useful marker for high grade prostate cancer. Prostate 2012.
53. Vosa U., Vooder T., Kolde R., Vilo J., Metspalu A., Annilo T. Meta-analysis of microRNA expression in lung cancer. Int. J. Cancer 2013, 132(12):2884-2893.
54. Wang J., Li J., Shen J., Wang C., Yang L., Zhang X. MicroRNA-182 downregulates metastasis suppressor 1 and contributes to metastasis of hepatocellular carcinoma. BMC Cancer 2012, 12:227.
55. Wang Y., Luo H., Li Y., Chen T., Wu S., Yang L. hsa-miR-96 up-regulates MAP4K1 and IRS1 and may function as a promising diagnostic marker in human bladder urothelial carcinomas. Mol. Med. Rep. 2012, 5(1):260-265.
56. Wang Y.Q., Guo R.D., Guo R.M., Sheng W., Yin L.R. MicroRNA-182 promotes cell growth, invasion and chemoresistance by targeting programmed cell death 4 (PDCD4) in human ovarian carcinomas. J. Cell. Biochem. 2013, 114(7):1464-1473.
57. Xu X., Dong Z., Yang Y., Yuan Z., Qu X., Kong B. The upregulation of signal transducer and activator of transcription 5-dependent microRNA-182 and microRNA-96 promotes ovarian cancer cell proliferation by targeting forkhead box O3 upon leptin stimulation. Int. J. Biochem. Cell Biol. 2012, 45(3):536-545.
58. Xu X.M., et al. Expression of miR-21, miR-31, miR-96 and miR-135b is correlated with the clinical parameters of colorectal cancer. Oncol. Lett. 2012, 4(2):339-345.
59. Yamada Y., et al. MiR-96 and miR-183 detection in urine serve as potential tumor markers of urothelial carcinoma: correlation with stage and grade, and comparison with urinary cytology. Cancer Sci. 2011, 102(3):522-529.
60. Yu S., et al. miRNA-96 suppresses KRAS and functions as a tumor suppressor gene in pancreatic cancer. Cancer Res. 2010, 70(14):6015-6025.
61. Yu J., Li A., Hong S.M., Hurban R.H., Goggins M. MicroRNA alterations of pancreatic intraepithelial neoplasias. Clin. Cancer Res. 2012, 18(4):981-992.
62. Zheng W.W., et al. Expression of microRNA-183 in stage II (gastric cancer and its association with Ezrin protein. Zhonghua Wei Chang Wai Ke Za Zhi 2012, 15(7):723-726.
63. Zhu W., Liu X., He J., Chen D., Huang Y., Zhang Y. Overexpression of members of the microRNA-183 family is a risk factor for lung cancer: a case control study. BMC Cancer 2011, 11:393.
64. Zhu J., et al. Down-regulation of miR-183 promotes migration and invasion of osteosarcoma by targeting Ezrin. Am. J. Pathol. 2012, 180(6):2440-2451.